Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2342)
All Articles published online
|
Apr 7, 2007 (publication date) through May 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lim YJ, Rhee JC, Bae YM, Chun WJ. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. World J Gastroenterol 2007; 13(13): 1947-1952 [PMID: 17461495 DOI: 10.3748/wjg.v13.i13.1947] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i13/1947.htm |
| Number | Citing Articles |
| 1 |
De-Qing Zhang, Qiang Guo, Jian-Hong Zhu, Wei-Chang Chen. Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer. World Journal of Surgical Oncology 2013; 11(1) doi: 10.1186/1477-7819-11-16
|
| 2 |
Anning Yin, Yingan Jiang, Xianfeng Zhang, Hesheng Luo. Overexpression of FADD enhances 5-fluorouracil-induced apoptosis in colorectal adenocarcinoma cells. Medical Oncology 2010; 27(2): 397 doi: 10.1007/s12032-009-9224-x
|
| 3 |
Xiao-Li Li, Chong-Zhi Wang, Sangeeta R. Mehendale, Shi Sun, Qi Wang, Chun-Su Yuan. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells. Cancer Chemotherapy and Pharmacology 2009; 64(6): 1097 doi: 10.1007/s00280-009-0966-0
|
| 4 |
Kazuhito Sasaki, Nelson H. Tsuno, Eiji Sunami, Kazushige Kawai, Kumiko Hongo, Masaya Hiyoshi, Manabu Kaneko, Koji Murono, Noriko Tada, Takako Nirei, Koki Takahashi, Joji Kitayama. Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study. Anti-Cancer Drugs 2012; 23(7): 675 doi: 10.1097/CAD.0b013e328353f8c7
|
| 5 |
Emilia Witkowska Nery, Elżbieta Jastrzębska, Kamil Żukowski, Wojciech Wróblewski, Michał Chudy, Patrycja Ciosek. Flow-through sensor array applied to cytotoxicity assessment in cell cultures for drug-testing purposes. Biosensors and Bioelectronics 2014; 51: 55 doi: 10.1016/j.bios.2013.07.023
|
| 6 |
Simona Dinicola, Veronica Morini, Pierpaolo Coluccia, Sara Proietti, Fabrizio D’Anselmi, Alessia Pasqualato, Maria Grazia Masiello, Alessandro Palombo, Giorgio De Toma, Mariano Bizzarri, Alessandra Cucina. Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs. Toxicology in Vitro 2013; 27(8): 2256 doi: 10.1016/j.tiv.2013.09.020
|
| 7 |
Anning Yin, Yingan Jiang, Xianfeng Zhang, Juan Zhao, Hesheng Luo. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo. European Journal of Pharmacology 2010; 649(1-3): 120 doi: 10.1016/j.ejphar.2010.09.040
|
| 8 |
Fatma M. Abdallah, Maged W. Helmy, Mohamed A. Katary, Asser I. Ghoneim. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2018; 391(12): 1399 doi: 10.1007/s00210-018-1557-6
|
| 9 |
Jin-Yi Wan, Haiqiang Yao, Chun-Feng Zhang, Wei-Hua Huang, Qihui Zhang, Zhi Liu, Yi Bi, Stephanie Williams, Chong-Zhi Wang, Chun-Su Yuan. Red American ginseng enhances the effect of fluorouracil on human colon cancer cells via both paraptosis and apoptosis pathways. Journal of Applied Biomedicine 2018; 16(4): 311 doi: 10.1016/j.jab.2018.05.002
|
| 10 |
Seung Mi Choi, Young Sik Cho, Geumi Park, Suk Kyeong Lee, Kyung-Soo Chun. Celecoxib induces apoptosis through Akt inhibition in 5-fluorouracil-resistant gastric cancer cells. Toxicological Research 2021; 37(1): 25 doi: 10.1007/s43188-020-00044-3
|
| 11 |
Mayur M. Patel, Bhoomika M. Patel. Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibition. European Journal of Pharmaceutical Sciences 2018; 121: 188 doi: 10.1016/j.ejps.2018.05.026
|
| 12 |
Motahare Atefinezhad, Ahmadreza Moghadamnia, Seyed Parsa Eftekhar, Ali Akbar Moghadamnia, Sohrab Kazemi, Alemayehu Toma. Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study. Journal of Tropical Medicine 2022; 2022: 1 doi: 10.1155/2022/5267861
|
| 13 |
Emily Chan, Bonnie LaFleur, Mace L. Rothenberg, Nipun Merchant, Albert Craig Lockhart, Bakula Trivedi, Christine H. Chung, Robert J. Coffey, Jordan D. Berlin. Dual Blockade of the EGFR and COX-2 Pathways. American Journal of Clinical Oncology 2011; 34(6): 581 doi: 10.1097/COC.0b013e3181fe46a1
|
| 14 |
Jun Wang, Wei Liu, Qing Zhao, Qi Qi, Na Lu, Yong Yang, Fei-Fei Nei, Jing-Jing Rong, Qi-Dong You, Qing-Long Guo. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma. Toxicology 2009; 256(1-2): 135 doi: 10.1016/j.tox.2008.11.014
|
| 15 |
Annika Bundscherer, Christian Hafner. Cancer Microenvironment and Therapeutic Implications. 2009; : 221 doi: 10.1007/978-1-4020-9576-4_12
|
| 16 |
James Todd Auman, Robert Church, Soo-Youn Lee, Mark A. Watson, James W. Fleshman, Howard L. Mcleod. Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation. European Journal of Cancer 2008; 44(12): 1754 doi: 10.1016/j.ejca.2008.05.010
|
| 17 |
Monica Susan, Ioana Macasoi, Iulia Pinzaru, Cristina Dehelean, Iosif Ilia, Razvan Susan, Ioana Ionita. In Vitro Assessment of the Synergistic Effect of Aspirin and 5-Fluorouracil in Colorectal Adenocarcinoma Cells. Current Oncology 2023; 30(7): 6197 doi: 10.3390/curroncol30070460
|
| 18 |
Heekyung Chung, Joy Chaudhry, Claudia G. Lopez, John M. Carethers. Cyclin E and histone H3 levels are regulated by 5-fluorouracil in a DNA mismatch repair-dependent manner. Cancer Biology & Therapy 2010; 10(11): 1147 doi: 10.4161/cbt.10.11.13447
|
| 19 |
Jaleh Varshosaz, Sara Riahi, Erfaneh Ghassami, Ali Jahanian-Najafabadi. Transferrin-targeted poly(butylene adipate)/terephthalate nanoparticles for targeted delivery of 5-fluorouracil in HT29 colorectal cancer cell line. Journal of Bioactive and Compatible Polymers 2017; 32(5): 503 doi: 10.1177/0883911517690756
|
| 20 |
Saumitra Gajjar, Vivek Bora, Bhoomika M. Patel. Repositioning of simvastatin for diabetic colon cancer: role of CDK4 inhibition and apoptosis. Molecular and Cellular Biochemistry 2023; 478(10): 2337 doi: 10.1007/s11010-023-04663-w
|
| 21 |
Wei Zhong Li, Xiao Yan Wang, Zu Guo Li, Jin Hua Zhang, Yan Qing Ding. Celecoxib enhances the inhibitory effect of cisplatin on Tca8113 cells in human tongue squamous cell carcinomain vivoandin vitro. Journal of Oral Pathology & Medicine 2010; doi: 10.1111/j.1600-0714.2009.00885.x
|
| 22 |
Vivekjyoti Banerjee, Neha Sharda, Jared Huse, Damandeep Singh, Daniil Sokolov, Steven J. Czinn, Thomas G. Blanchard, Aditi Banerjee. Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: Using the Chou-Talalay combination index method. European Journal of Pharmacology 2021; 897: 173919 doi: 10.1016/j.ejphar.2021.173919
|